Zacks Research Issues Optimistic Estimate for COO Earnings

The Cooper Companies, Inc. (NASDAQ:COO) – Analysts at Zacks Research boosted their Q3 2027 earnings estimates for Cooper Companies in a report issued on Thursday, March 26th. Zacks Research analyst Team now expects that the medical device company will earn $1.25 per share for the quarter, up from their prior forecast of $1.24. The consensus estimate for Cooper Companies’ current full-year earnings is $3.98 per share.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The firm’s revenue was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS.

Other analysts have also recently issued research reports about the company. Stifel Nicolaus set a $95.00 price objective on Cooper Companies and gave the company a “buy” rating in a research report on Friday, December 5th. Citigroup cut their price target on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a research note on Friday, March 6th. Mizuho set a $100.00 price target on shares of Cooper Companies and gave the company an “outperform” rating in a research report on Friday, December 5th. Morgan Stanley increased their price objective on shares of Cooper Companies from $76.00 to $83.00 and gave the stock an “equal weight” rating in a research note on Monday, December 8th. Finally, Weiss Ratings raised shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $90.79.

Cooper Companies Stock Performance

COO stock opened at $71.50 on Monday. The company has a market cap of $13.95 billion, a P/E ratio of 35.40, a price-to-earnings-growth ratio of 1.79 and a beta of 1.02. Cooper Companies has a 1 year low of $61.78 and a 1 year high of $89.83. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The stock’s fifty day moving average price is $78.38 and its 200-day moving average price is $76.26.

Institutional Trading of Cooper Companies

Several hedge funds have recently bought and sold shares of the stock. Root Financial Partners LLC lifted its position in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares in the last quarter. Bell Investment Advisors Inc increased its holdings in Cooper Companies by 106.3% in the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after acquiring an additional 219 shares in the last quarter. CYBER HORNET ETFs LLC bought a new stake in Cooper Companies during the 2nd quarter worth approximately $36,000. True Wealth Design LLC raised its stake in Cooper Companies by 484.8% during the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after acquiring an additional 383 shares during the period. Finally, Cromwell Holdings LLC lifted its holdings in Cooper Companies by 128.8% during the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after purchasing an additional 273 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.